[1]伊远学,刘晓平,李宝金,等.微囊化腺病毒介导的Bcl-2基因转染对缺血再灌注损伤肠黏膜的保护作用[J].第三军医大学学报,2010,32(14):1516-1519.
 Yi Yuanxue,Liu Xiaoping,Li Baojin,et al.Microencapsulated adenovirus-mediated gene transfer of Bcl-2 protects rat intestinal mucosa after ischemia-reperfusion injury[J].J Third Mil Med Univ,2010,32(14):1516-1519.
点击复制

微囊化腺病毒介导的Bcl-2基因转染对缺血再灌注损伤肠黏膜的保护作用(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
32卷
期数:
2010年第14期
页码:
1516-1519
栏目:
论著
出版日期:
2010-07-30

文章信息/Info

Title:
Microencapsulated adenovirus-mediated gene transfer of Bcl-2 protects rat intestinal mucosa after ischemia-reperfusion injury
作者:
伊远学刘晓平李宝金张超冷希圣刘筑罗效梅杨瑞兵
北京大学香港科技大学医学中心,北京大学深圳医院肝胆腔镜外科;武警重庆总队医院检验科
Author(s):
Yi Yuanxue Liu Xiaoping Li Baojin Zhang Chao Leng Xisheng Liu Zhu Luo XiaomeiYang Ruibing
Department of Hepatobiliary and Laparoscopic Surgery, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong Province, 518036; Department of Clinical Laboratory, Chongqing Corps Hospital of Chinese People’s Armed Police Forces, Chongqing, 400061, China
关键词:
小肠缺血再灌注损伤基因转染Bcl-2微囊腺病毒载体
Keywords:
intestinal mucosa ischemia and reperfusion gene transfection microcapsule adenovirus vector bcl-2 gene
分类号:
R364.12;R574;R966
文献标志码:
A
摘要:
目的    研究微囊化重组腺病毒AdCMV/Bcl-2转染对缺血再灌注损伤肠黏膜的保护作用及其机制。    方法    利用气体雾化技术将携带Bcl-2 基因的复制缺陷型重组腺病毒AdCMV/Bcl-2微囊化,检测其在人工胃、肠液中的融出率;将等量的重组腺病毒通过静脉注射、腹腔注射与口服微囊3种转染途径转染大鼠,应用RT-PCR和Western blot方法检测目的基因Bcl-2在小肠中的表达,并检测各组大鼠伤后血浆内毒素、二胺氧化酶(DAO)、D-乳酸含量和肠上皮细胞凋亡数量的变化。    结果    制备的微囊在人工胃液中仅有少量崩解,而在肠液中40 min崩解融出率即达到(57.2±3.9)%,肠溶性良好;AdCMV/Bcl-2转染后48 h大鼠肠黏膜Bcl-2基因的表达显著增强,其中,口服微囊组Bcl-2表达最强;AdCMV/Bcl-2转染使大鼠肠上皮细胞凋亡减少,伤后血浆D-乳酸、DAO及内毒素水平显著降低(P<0.01)。    结论    复制缺陷型重组腺病毒微囊化可保护其免受胃液损伤,并在肠道中被释放吸收。AdCMV/Bcl-2转染提高肠黏膜组织Bcl-2的表达在缺血再灌注损伤过程中可显著保护肠黏膜屏障功能。
Abstract:
Objective    To investigate the protective effects of microencapsulated adenovirus-mediated gene transfer of Bcl-2 on intestinal mucosa in rats after ischemia-reperfusion injury and underlying mechanism.     Methods    Alginate microcapsules containing the recombinant adenovirus AdCMV/Bcl-2 was prepared by using air atomization technique. Its acid resistance and dissolution in intestinal fluid were tested in artificial gastric juice and intestinal fluid. After the microencapsulated adenovirus (5×109 PFU) were injected by venous and intraperitoneal injection, and oral taking into the rats in 48 h before ligating superior mesenteric artery for 1 h followed by reperfusing for 6 h (ischemia-reperfusion injury), the expression of Bcl-2 in intestinal mucosa was detected by RT-PCR and Western blot analysis. The protective role of Bcl-2 in the intestinal mucosa in rats was analyzed by measuring plasma levels of endotoxin, D-lactic acid, and DAO.     Results    The recombinant adenovirus AdCMV/Bcl-2 contained in microcapsules was still survivable in vitro and also could  transfect and proliferate in 293 cells.The prepared microcapsule was almost insoluble in the simulated gastric juice but soluble in the simulated intestinal fluid in which the solution ratio arrived to 57.2% at 40 min. The AdCMV/Bcl-2 transfection in vivo successfully induced Bcl-2 over-expression in the intestinal mucosa, which protected the intestinal mucosa against ischemia and reperfusion injury. The AdCMV/Bcl-2 transfection in vivo attenuated intestinal epithelial cell apoptosis and structural mucosal damages, and decreased plasma endotoxin, DAO and D-lactic acid content following ischemia and reperfusion.     Conclusion    The AdCMV/Bcl-2 transfection in vivo successfully induces Bcl-2 over-expression in the intestinal mucosa, and protects the intestinal mucosa against the ischemia and reperfusion injury through attenuating intestinal epithelial cell apoptosis and decreasing plasma contents of endotoxin, D-lactic acid, and DAO. The microencapsulated adenovirus taken orally circumvents the injury in the stomach and exerts protective effect during the ischemia and reperfusion injury in intestinal mucosa. Our results suggest the microcapsulation of adenovirus might provide an effective means for the gene therapy in clinical application.

参考文献/References:

伊远学,刘晓平,李宝金,等. 微囊化腺病毒介导的Bcl-2基因转染对缺血再灌注损伤肠黏膜的保护作用[J].第三军医大学学报,2010,32(14):1516-1519.

相似文献/References:

[1]许礼发,王晓春,李朝品.猪巨吻棘头虫致小儿肠穿孔1例[J].第三军医大学学报,2012,34(22):2343.
[2]陈新,成名翔,龚建平,等.沉默供体肝脏内核糖体蛋白S3基因减轻大鼠移植肝脏缺血再灌注损伤[J].第三军医大学学报,2011,33(14):1441.
 Chen Xin,Cheng Mingxiang,Gong Jianping,et al.Silencing ribosome protein S3 gene in donor livers reduces ischemia/reperfusion injury following orthotopic liver transplantation in rats[J].J Third Mil Med Univ,2011,33(14):1441.
[3]徐广民,陶国才,易斌.异氟烷对大鼠肝脏缺血再灌注损伤时细胞间黏附分子-1表达的影响[J].第三军医大学学报,2008,30(03):241.
 XU Guang-min,TAO Guo-cai,YI Bin.Effect of Isoflurane on ICAM-1 expression in rats during liver ischemiareperfusion injury[J].J Third Mil Med Univ,2008,30(14):241.
[4]许永庆,戴朝六,崔凯,等.谷氨酰胺在肝脏缺血再灌注损伤中对肠道黏膜保护作用[J].第三军医大学学报,2007,29(11):1050.
 XU Yong-qing,DAI Chao-liu,CUI Kai,et al.Protective effect of glutamine on intestinal mucosa during hepatic ischemia/reperfusion injury in rats[J].J Third Mil Med Univ,2007,29(14):1050.
[5]房殿春.消化系统疾病研究进展[J].第三军医大学学报,2009,31(01):6.
[6]方针强,刘永亮,王祥卫,等.hBMP-7修饰的骨髓间充质干细胞对肾脏BMP-7的影响[J].第三军医大学学报,2011,33(15):1590.
 Fang Zhenqiang,Liu Yongliang,Wang Xiangwei,et al.hBMP-7-modified bone marrow mesenchymal stem cells attenuate kidney ischemia-reperfusion injury in rabbits[J].J Third Mil Med Univ,2011,33(14):1590.
[7]梅峰,于彬,马华,等.豚鼠空肠吻合术后ICCs的再生及细胞网络再形成研究[J].第三军医大学学报,2005,27(05):376.
[8]刘志恒,禹晓东,王海强,等.维生素C与小剂量激素联用对急性脊髓缺血再灌注损伤的保护作用[J].第三军医大学学报,2010,32(08):814.
 Liu Zhiheng,Yu Xiaodong,Wang Haiqiang,et al.Protective effect of methylprednisolone combined with ascorbic acid on acute spinal cord I/R injury in rabbits[J].J Third Mil Med Univ,2010,32(14):814.
[9]王涛,艾国平,杜智勇,等.轻度肠型放-烧复合伤救治的实验研究[J].第三军医大学学报,2005,27(21):2099.
[10]王群英,刘新伟,杨海燕,等.硝酸甘油预处理的心肌保护作用及对Caveolin-3表达的影响[J].第三军医大学学报,2010,32(24):2627.
 Wang Qunying,Liu Xinwei,Yang Haiyan,et al.Nitroglycerin preconditioning protects heart ischemia-reperfusion injury in rats by improving Caveolin-3 expression[J].J Third Mil Med Univ,2010,32(14):2627.

更新日期/Last Update: 2010-07-19